CUREVAC N V's ticker is CVAC and the CUSIP is N2451R105. A total of 114 filers reported holding CUREVAC N V in Q1 2022. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,772 | -41.4% | 3,187,699 | -10.6% | 0.00% | -40.0% |
| Q2 2023 | $37,138 | +39.7% | 3,564,026 | -6.6% | 0.01% | +25.0% |
| Q1 2023 | $26,583 | +695.9% | 3,813,896 | +588.6% | 0.00% | +300.0% |
| Q4 2022 | $3,340 | -100.0% | 553,865 | +22.9% | 0.00% | 0.0% |
| Q1 2022 | $8,837,000 | -48.9% | 450,642 | -10.6% | 0.00% | -50.0% |
| Q4 2021 | $17,297,000 | -34.5% | 504,148 | +4.3% | 0.00% | 0.0% |
| Q3 2021 | $26,402,000 | +11582.3% | 483,371 | +15624.5% | 0.00% | – |
| Q2 2021 | $226,000 | -99.8% | 3,074 | -99.8% | 0.00% | -100.0% |
| Q1 2021 | $125,308,000 | +21.9% | 1,370,088 | +8.1% | 0.01% | +18.2% |
| Q4 2020 | $102,780,000 | +83.6% | 1,267,798 | +5.4% | 0.01% | +83.3% |
| Q3 2020 | $55,973,000 | – | 1,202,421 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,625,943 | $11,332,823 | 10.01% |
| RA Capital Management | 12,245,955 | $85,354,306 | 1.93% |
| Avidity Partners Management LP | 3,550,000 | $24,743,500 | 0.82% |
| Camber Capital Management LP | 1,250,000 | $8,713 | 0.27% |
| Ghisallo Capital Management LLC | 100,000 | $697,000 | 0.17% |
| FOX RUN MANAGEMENT, L.L.C. | 31,278 | $218,008 | 0.07% |
| Alyeska Investment Group, L.P. | 1,060,382 | $7,390,863 | 0.06% |
| Green Alpha Advisors, LLC | 12,351 | $86,086 | 0.06% |
| Virtus ETF Advisers LLC | 14,114 | $98,375 | 0.05% |
| Quantamental Technologies LLC | 11,146 | $77,688 | 0.04% |